Home > Suppliers > Abivax SA
Catalogue

Recommend Products

Abivax SA

France, Manufacturer, Hits: 83, Updated:5/14/2020
5, rue de la Baume 75008 Paris |
Company Profile
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Abivax is listed on Euronext compartment B (ISIN: FR0012333284 – Mnémo: ABVX). Based in Paris and Montpellier, Abivax has two drug candidates in clinical development, ABX464 to treat severe inflammatory diseases, and ABX196 to treat hepatocellular carcinoma.